月旦知識庫
 
  1. 熱門:
 
首頁 臺灣期刊   法律   公行政治   醫事相關   財經   社會學   教育   其他 大陸期刊   核心   重要期刊 DOI文章
生物醫學暨檢驗科學雜誌 本站僅提供期刊文獻檢索。
  【月旦知識庫】是否收錄該篇全文,敬請【登入】查詢為準。
最新【購點活動】


篇名
建立健康成人血小板凝集試驗的生物參考區間
並列篇名
Establishment of Platelet Aggregation Test Reference Intervals in Healthy Adults
作者 鄭進裕張碧珠張志新許呈安林賓賓
中文摘要
血小板凝集試驗是用來評估血小板的凝集功能用以診斷先天性血小板功能異常疾病。然而,因檢體收集不易及檢驗流程繁瑣等原因,國內尚未有實驗室建立血小板凝集試驗生物參考區間。為了針對台灣族群建立血小板凝集試驗正常參考區間,我們一共收集125位健康成人之富含血小板血漿(PRP)和缺血小板血漿(PPP)並利用BIO/DATA Aggregation Profiler血小板凝集分析儀進行分析。本研究中共使用四種血小板激活劑(agonist)分別為瑞斯托菌素(0.3-1.5 mg/mL)、二磷酸腺苷(2-20 μM)、膠原蛋白(1-5 μg/mL)與腎上腺素(1-100 μM)。分析結果利用SPSS軟體進行kolmogorov-smirnov test分析並以最終凝集率(%)表示。各項不同濃度激活劑(agonist)之生物參考區間建立如下:Ristocetin 1.5 mg/mL(84.43-97.23%)、Ristocetin 1.2 mg/mL(81.38-93.82%)、Ristocetin 1.0 mg/mL(56.58-93.54%)、Ristocetin 0.6 mg/mL(3.64-9.12%)、Ristocetin 0.3 mg/mL(4.32-8.96%)、ADP 20 μM(72.80-88.42%)、ADP 8 μM(62.93-86.95%)、ADP 6 μM(57.50-81.98%)、ADP 2 μ M(9.81-69.91%)、Collagen 5 μg/mL(78.98-92.10%)、Collagen 3.3 μg/mL(72.47-90.53%)、Collagen 2.0 μg/mL(59.46-86.74%)、Collagen 1.0 μg/mL(39.91-87.29%)、Epinephrine 100 μM(54.83-93.31%)、Epinephrine 10 μM(51.82-94.59%)及Epinephrine 1 μM(11.91-67.07%)。總結,本研究結果不僅能夠提供臨床醫師作為正確診斷的依據,亦可提供給其他實驗室做為參考的指標。
英文摘要
Platelet aggregation test can be used to evaluate the platelet aggregation function for the diagnosis of inherited platelet function abnormal diseases. However, the reference intervals of platelet aggregation test were not yet well established in Taiwan due to difficult sample collection and complicated examination procedure. To establish the reference intervals of platelet aggregation for Taiwanese population, platelet-rich plasma (PRP) and platelet-poor plasma (PPP) specimens were collected from 125 healthy adults and analyzed by BIO/DATA Aggregation Profiler aggregometer. In this study, four kinds of agonists were used, including Ristocetin (0.3-1.5 mg/mL), ADP (2-20 μM), Collagen (1-5 μg/mL), Epinephrine (1-100 μM). Results were statistical analyzed by kolmogorov-smirnov test using the SPSS software and were shown as final aggregation rate (%). The reference intervals of each agonists with different concentration were established as Ristocetin 1.5 mg/mL (84.43-97.23%), Ristocetin 1.2 mg/mL (81.38-93.82%), Ristocetin 1.0 mg/mL (56.58-93.54%), Ristocetin 0.6 mg/mL (3.64-9.12%), Ristocetin 0.3 mg/mL (4.32-8.96%), ADP 20 μM (72.80-88.42%), ADP 8 μM (62.93-86.95%), ADP 6 μM (57.50-81.98%), ADP 2 μM (9.81-69.91%), Collagen 5 μg/mL (78.98-92.10%), Collagen 3.3 μg/mL (72.47- 90.53%), Collagen 2.0 μg/mL (59.46-86.74%), Collagen 1.0 μg/mL (39.91-87.29%) and Epinephrine 100 μM (54.83-93.31%), Epinephrine 10 μM (51.82-94.59%) and Epinephrine 1 μM (11.91-67.07%), respectively. In conclusion, these results can not only be used for more accurate diagnosis but also be a reference for other laboratories.
起訖頁 76-83
關鍵詞 血小板凝集試驗瑞斯托菌素二磷酸腺苷膠原腎上腺素Platelet Aggregation TestRistocetinAdenosine-5'-Diphosphate (ADP)CollagenEpinephrine
刊名 生物醫學暨檢驗科學雜誌  
期數 202006 (32:2期)
出版單位 台灣醫事檢驗學會
該期刊-上一篇 以腸道微生物相為基礎的整合多體學研究:次世代中醫草藥學研究
該期刊-下一篇 血球數位影像處理系統Sysmex DI 60的效能與運用
 

新書閱讀



最新影音


優惠活動




讀者服務專線:+886-2-23756688 傳真:+886-2-23318496
地址:臺北市館前路28 號 7 樓 客服信箱
Copyright © 元照出版 All rights reserved. 版權所有,禁止轉貼節錄